Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cortical Response to Noxious and Auditory Stimuli Under General Anesthesia
NCT02703090Completed
- Sponsor
- Boston Children's Hospital
- Start
- Oct 2016
- Primary completion
- Mar 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of remifentanil in pain (3 arms), sponsored by Boston Children's Hospital. Primary endpoints: Peak Change in Cortical Oxyhemoglobin Concentration to Ablation, Minimum Change in Cortical Oxyhemoglobin Concentration to Ablation and 1 more. Started Oct 2016; status: completed.
02
Drugs
remifentanil
03
Conditions
pain
Beyond the preview
Go deeper on NCT02703090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02703090.